España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Medicenna Therapeutics
MDNAF
OTCQX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9950
0.06
6.13%
At close: -
Get Report
Comment
Medicenna Therapeutics (MDNAF) Forecast
News
Earnings
Medicenna Therapeutics (MDNAF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Medicenna Therapeutics (OTC:MDNAF) Stock
Medicenna Therapeutics Stock (OTC: MDNAF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 09, 2023
Medicenna To Present 4 Year Follow-Up Phase 2...
Benzinga Newsdesk
Friday, May 29, 2020
Medicenna Updates Efficacy Results From Phase...
Benzinga Newsdesk
Wednesday, May 20, 2020
MDNA.TO: Data on MDNA55 and MDNA11 to be Presented at ASCO 2020…
Zacks Small Cap Research
Thursday, April 16, 2020
The Spread of COVID-19 Has Caused Massive Volume Spikes In Securities On OTC Markets
Spencer Israel
Monday, March 30, 2020
MDNA.TO: Encouraging MDNA19 Data in Non-Human Primates; Financing Funds Company Through End of 2022…
Zacks Small Cap Research
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Tuesday, February 25, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Friday, February 21, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Thursday, February 20, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Wednesday, February 19, 2020
MDNA.TO: Cash Sufficient Through the End of 2020…
Zacks Small Cap Research
Tuesday, January 14, 2020
MDNA.TO: End-of-Phase 2 Meeting with FDA for MDNA55 in 1Q20…
Zacks Small Cap Research
Friday, December 27, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Friday, December 20, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Monday, December 02, 2019
MDNA.TO: Updated MDNA55 P2b Data Continues to Exceed Currently Available rGBM Therapies…
Zacks Small Cap Research
Monday, November 25, 2019
Medicenna Highlights Efficacy In Phase 2b MDN...
Benzinga Newsdesk
Thursday, November 21, 2019
Medicenna Therapeutics Highlights Results On ...
Benzinga Newsdesk
Thursday, September 12, 2019
Medicenna Reports Will Present Latest Data Fr...
Benzinga Newsdesk
Wednesday, July 31, 2019
Medicenna Selects its Lead Immuno-Oncology Cl...
Benzinga Newsdesk
Monday, June 03, 2019
Medicenna Earlier Reported Presentation Of Cl...
Benzinga Newsdesk
Thursday, May 16, 2019
Mediceena Highlights Presentation At ASCO
Benzinga Newsdesk
